메뉴 건너뛰기




Volumn 15, Issue 2, 2019, Pages 130-137

Novel guanosine derivatives as anti-HCV NS5b polymerase: A QSAR and molecular docking study

Author keywords

Guanosine inhibitors; Hepatitis c virus (HCV); NS5b polymerase; Protein ligand docking; QSAR; Sofosbuvir

Indexed keywords

ANTIVIRUS AGENT; GUANOSINE DERIVATIVE; IDX 184; NONSTRUCTURAL PROTEIN 5B; SOFOSBUVIR; GUANOSINE; NS-5 PROTEIN, HEPATITIS C VIRUS; VIRAL PROTEIN;

EID: 85062083382     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/1573406414666181015152511     Document Type: Article
Times cited : (36)

References (33)
  • 1
    • 79958830099 scopus 로고    scopus 로고
    • Hepatitis C virus resistance to protease inhibitors
    • Halfon, P.; Locarnini, S. Hepatitis C virus resistance to protease inhibitors. J. Hepatol., 2011, 55(1), 192-206.
    • (2011) J. Hepatol , vol.55 , Issue.1 , pp. 192-206
    • Halfon, P.1    Locarnini, S.2
  • 2
    • 16844366354 scopus 로고    scopus 로고
    • Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis
    • Genovese, D.; Dettori, S.; Argentini, C.; Villano, U.; Chionne, P.; Angelico, M.; Rapicetta, M. Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis. J. Clin. Microbiol., 2005, 43(4), 1902-1909.
    • (2005) J. Clin. Microbiol , vol.43 , Issue.4 , pp. 1902-1909
    • Genovese, D.1    Dettori, S.2    Argentini, C.3    Villano, U.4    Chionne, P.5    Angelico, M.6    Rapicetta, M.7
  • 5
    • 79961171672 scopus 로고    scopus 로고
    • Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors
    • Das, D.; Hong, J.; Chen, S.H.; Wang, G.; Beigelman, L.; Seiwert, S.D.; Buckman, B.O. Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors. Bioorg. Med. Chem., 2011, 19(16), 4690-703.
    • (2011) Bioorg. Med. Chem , vol.19 , Issue.16 , pp. 4690-4703
    • Das, D.1    Hong, J.2    Chen, S.H.3    Wang, G.4    Beigelman, L.5    Seiwert, S.D.6    Buckman, B.O.7
  • 6
    • 35748953422 scopus 로고    scopus 로고
    • Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus
    • De Francesco, R.; Carfí, A. Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. Adv. Drug Deliv. Rev., 2007, 59(12), 1242-1262.
    • (2007) Adv. Drug Deliv. Rev. , vol.59 , Issue.12 , pp. 1242-1262
    • De Francesco, R.1    Carfí, A.2
  • 7
    • 0037367315 scopus 로고    scopus 로고
    • Approaching a new era for hepatitis C virus therapy: Inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase
    • De Francesco, R.; Tomei, L.; Altamura, S.; Summa, V.; Migliaccio, G. Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiv. Res., 2003, 58(1), 1-16.
    • (2003) Antiv. Res , vol.58 , Issue.1 , pp. 1-16
    • De Francesco, R.1    Tomei, L.2    Altamura, S.3    Summa, V.4    Migliaccio, G.5
  • 9
    • 84904756999 scopus 로고    scopus 로고
    • Daclatasvir plus sofosbuvir for HCV infection: An oral combination therapy with high antiviral efficacy
    • Asselah, T. Daclatasvir plus sofosbuvir for HCV infection: an oral combination therapy with high antiviral efficacy. J. Hepatol., 2014, 61(2), 435-8.
    • (2014) J. Hepatol , vol.61 , Issue.2 , pp. 435-438
    • Asselah, T.1
  • 11
    • 84856410313 scopus 로고    scopus 로고
    • Antiviral strategies in hepatitis C virus infection
    • Sarrazin, C.; Hézode, C.; Zeuzem, S.; Pawlotsky, J.-M. Antiviral strategies in hepatitis C virus infection. J. Hepatol., 2012, 56, S88-S100.
    • (2012) J. Hepatol , vol.56 , pp. S88-S100
    • Sarrazin, C.1    Hézode, C.2    Zeuzem, S.3    Pawlotsky, J.-M.4
  • 12
    • 33749249403 scopus 로고    scopus 로고
    • Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors
    • Yan, S.; Appleby, T.; Larson, G.; Wu, J.Z.; Hamatake, R.; Hong, Z.; Yao, N. Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors. Bioorg. Med. Chem. Lett., 2006, 16(22), 5888-5891.
    • (2006) Bioorg. Med. Chem. Lett , vol.16 , Issue.22 , pp. 5888-5891
    • Yan, S.1    Appleby, T.2    Larson, G.3    Wu, J.Z.4    Hamatake, R.5    Hong, Z.6    Yao, N.7
  • 13
    • 33845619375 scopus 로고    scopus 로고
    • Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure
    • Yan, S.; Larson, G.; Wu, J.Z.; Appleby, T.; Ding, Y.; Hamatake, R.; Hong, Z.; Yao, N. Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure. Bioorg. Med. Chem. Lett., 2007, 17(1), 63-67.
    • (2007) Bioorg. Med. Chem. Lett , vol.17 , Issue.1 , pp. 63-67
    • Yan, S.1    Larson, G.2    Wu, J.Z.3    Appleby, T.4    Ding, Y.5    Hamatake, R.6    Hong, Z.7    Yao, N.8
  • 14
    • 29044433435 scopus 로고    scopus 로고
    • A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background
    • Graham, D.J.; Stahlhut, M.; Flores, O.; Olsen, D.B.; Hazuda, D. J.; LaFemina, R.L.; Ludmerer, S.W. A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background. Antiv. Res., 2006, 69(1), 24-30.
    • (2006) Antiv. Res. , vol.69 , Issue.1 , pp. 24-30
    • Graham, D.J.1    Stahlhut, M.2    Flores, O.3    Olsen, D.B.4    Hazuda, D.J.5    LaFemina, R.L.6    Ludmerer, S.W.7
  • 15
    • 84960158342 scopus 로고    scopus 로고
    • IDX-184 is a superior HCV directacting antiviral drug: A QSAR study
    • Elfiky, A.A.; Elshemey, W.M. IDX-184 is a superior HCV directacting antiviral drug: a QSAR study. Med. Chem. Res., 2016, 25, 1005-1008.
    • (2016) Med. Chem. Res , vol.25 , pp. 1005-1008
    • Elfiky, A.A.1    Elshemey, W.M.2
  • 16
    • 84925270533 scopus 로고    scopus 로고
    • 2′-Methylguanosine Prodrug (IDX-184), Phosphoramidate Prodrug (Sofosbuvir), Diisobutyryl Prodrug (R7128) Are Better Than Their Parent Nucleotides and Ribavirin in Hepatitis C Virus Inhibition: A Molecular Modeling Study
    • Elfiky, A.A.; Elshemey, W.M.; Gawad, W. A. 2′-Methylguanosine Prodrug (IDX-184), Phosphoramidate Prodrug (Sofosbuvir), Diisobutyryl Prodrug (R7128) Are Better Than Their Parent Nucleotides and Ribavirin in Hepatitis C Virus Inhibition: A Molecular Modeling Study. J. Comput. Theor. Nanosci., 2015, 12(3), 376-386.
    • (2015) J. Comput. Theor. Nanosci. , vol.12 , Issue.3 , pp. 376-386
    • Elfiky, A.A.1    Elshemey, W.M.2    Gawad, W.A.3
  • 17
    • 84988421322 scopus 로고    scopus 로고
    • Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials
    • Elfiky, A.A. Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials. J. Med. Virol., 2016, 88, 2044-2051.
    • (2016) J. Med. Virol , vol.88 , pp. 2044-2051
    • Elfiky, A.A.1
  • 18
    • 84892405001 scopus 로고    scopus 로고
    • The Electronic and quantitative structure activity relationship properties of modified telaprevir compounds as hcv ns3 protease inhibitors
    • Saleh, N.A.; Elfiky, A.A.; Ezat, A.A.; Elshemey, W.M.; Ibrahim, M. The Electronic and quantitative structure activity relationship properties of modified telaprevir compounds as hcv ns3 protease inhibitors. J. Computa. Theore. Nanosci., 2014, 11(2), 544-548.
    • (2014) J. Computa. Theore. Nanosci , vol.11 , Issue.2 , pp. 544-548
    • Saleh, N.A.1    Elfiky, A.A.2    Ezat, A.A.3    Elshemey, W.M.4    Ibrahim, M.5
  • 21
    • 84872683113 scopus 로고    scopus 로고
    • Molecular modeling comparison of the performance of NS5b polym erase inhibitor (PSI-7977) on prevalent HCV genotypes
    • Elfiky, A.A.; Elshemey, W.M.; Gawad, W.A.; Desoky, O.S. Molecular modeling comparison of the performance of NS5b polym erase inhibitor (PSI-7977) on prevalent HCV genotypes. Protein J., 2013, 32(1), 75-80.
    • (2013) Protein J , vol.32 , Issue.1 , pp. 75-80
    • Elfiky, A.A.1    Elshemey, W.M.2    Gawad, W.A.3    Desoky, O.S.4
  • 22
    • 80051670512 scopus 로고    scopus 로고
    • Protein-protein HADDocking using exclusively pseudocontact shifts
    • Schmitz, C.; Bonvin, A.M. Protein-protein HADDocking using exclusively pseudocontact shifts. J. Biomol NMR, 2011, 50(3), 263-6.
    • (2011) J. Biomol NMR , vol.50 , Issue.3 , pp. 263-266
    • Schmitz, C.1    Bonvin, A.M.2
  • 23
    • 78650674078 scopus 로고    scopus 로고
    • Safety and pharmacokinetics of IDX184, a livertargeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects
    • Zhou, X. J.; Pietropaolo, K.; Chen, J.; Khan, S.; Sullivan-Bolyai, J.; Mayers, D. Safety and pharmacokinetics of IDX184, a livertargeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects. Antimicrob. Agents Chemother., 2011, 55(1), 76-81.
    • (2011) Antimicrob. Agents Chemother , vol.55 , Issue.1 , pp. 76-81
    • Zhou, X.J.1    Pietropaolo, K.2    Chen, J.3    Khan, S.4    Sullivan-Bolyai, J.5    Mayers, D.6
  • 24
    • 23744446809 scopus 로고    scopus 로고
    • Giacomo Paonessa, Raffaele De Francesco and Giovanni Migliaccio, HCV antiviral resistance: The impact of in vitro studies on the development of antiviral agents targeting the viral NS5B polymerase
    • Licia Tomei, S.A. Giacomo Paonessa, Raffaele De Francesco and Giovanni Migliaccio, HCV antiviral resistance: the impact of in vitro studies on the development of antiviral agents targeting the viral NS5B polymerase. Antiv. Chem. Chemother., 2005, 16, 225-245.
    • (2005) Antiv. Chem. Chemother , vol.16 , pp. 225-245
    • Licia Tomei, S.A.1
  • 25
    • 84912061839 scopus 로고    scopus 로고
    • The QSAR and docking calculations of fullerene derivatives as HIV-1 protease inhibitors
    • Saleh, N.A. The QSAR and docking calculations of fullerene derivatives as HIV-1 protease inhibitors. Spectrochim Acta A Mol. Biomol. Spectrosc., 2014, 136PC, 1523-1529.
    • (2014) Spectrochim Acta A Mol. Biomol. Spectrosc , Issue.136PC , pp. 1523-1529
    • Saleh, N.A.1
  • 26
    • 85022150820 scopus 로고    scopus 로고
    • Hepatitis C Viral Polymerase Inhibition using Directly Acting Antivirals, A Computational Approach
    • A, M., Ed. Austin publishing group: USA, In press
    • Elfiky, A.A.; Gawad, W.A.; Elshemey, W.M. Hepatitis C Viral Polymerase Inhibition using Directly Acting Antivirals, A Computational Approach. In Software and Techniques for Bio-Molecular Modeling, A, M., Ed. Austin publishing group: USA, In press.
    • Software and Techniques for Bio-Molecular Modeling
    • Elfiky, A.A.1    Gawad, W.A.2    Elshemey, W.M.3
  • 28
    • 0037470586 scopus 로고    scopus 로고
    • Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): Structural evidence for nucleotide import and de-novo initiation
    • O’Farrell, D.; Trowbridge, R.; Rowlands, D.; Jäger, J. Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): Structural evidence for nucleotide import and de-novo initiation. J. Mol. Biol., 2003, 326(4), 1025-1035.
    • (2003) J. Mol. Biol. , vol.326 , Issue.4 , pp. 1025-1035
    • O’Farrell, D.1    Trowbridge, R.2    Rowlands, D.3    Jäger, J.4
  • 31
    • 84899047097 scopus 로고    scopus 로고
    • Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: A review of its clinical potential
    • Stedman, C. Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential. Therapeut. Advan. Gastroenterol., 2014, 7(3), 131-140.
    • (2014) Therapeut. Advan. Gastroenterol , vol.7 , Issue.3 , pp. 131-140
    • Stedman, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.